Showing results (21-30 of 147) with videos related to
Sort By:
Pageof 15
Applied Health Economics and Health Policy|November 3, 2014
Kinky thresholds revisited: opportunity costs differ in the NE and SW quadrantsSimon EckermannFrontiers in Public Health|December 30, 2022
Globally optimal trial design and risk sharing arrangements are key to avoiding opportunity costs of delay and enabling equitable, feasible and effective global vaccine research and implementation in current or future pandemicsSimon EckermannFrontiers in Public Health|March 21, 2024
Aligning opportunity cost and net benefit criteria: the health shadow priceSimon EckermannClinical Trials (London, England)|April 17, 2020
Bayesian methods for pilot studiesAndrew R Willan, Lehana ThabanePharmacoeconomics|October 28, 2006
'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness dataAndrea Manca, Andrew R WillanSocial Science & Medicine (1982)|November 17, 2012
Including quality attributes in efficiency measures consistent with net benefit: creating incentives for evidence based medicine in practiceSimon Eckermann, Tim CoelliPharmacoeconomics|February 12, 2014
Can the real opportunity cost stand up: displaced services, the straw man outside the roomSimon Eckermann, Brita PekarskyStatistics in Medicine|April 5, 2005
The value of information and optimal clinical trial designAndrew R Willan, Eleanor M PintoClinical Trials (London, England)|December 25, 2012
Determining optimal sample sizes for multistage adaptive randomized clinical trials from an industry perspective using value of information methodsMaggie H Chen, Andrew R WillanStatistics in Medicine|February 20, 2007
Semi-parametric regression models for cost-effectiveness analysis: improving the efficiency of estimation from censored dataEleanor M Pullenayegum, Andrew R WillanPageof 15